AsOf

Recorded or changed on this day 2026-11-08

351–400 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,796,586,000 United States dollar
Abbott Laboratories cash and equivalents: 3,796,586,000 United States dollar, claim clm_9FCEFBC20CAB · ended · superseded by clm_AD5025D43C51 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,446,025,000 United States dollar
Abbott Laboratories quarterly revenue: 5,446,025,000 United States dollar, claim clm_A00248C0A983 · ended · superseded by clm_05BD8CC8CEE0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 892,000,000 United States dollar
Abbott Laboratories quarterly research and development: 892,000,000 United States dollar, claim clm_A04DCE763037 · ended · superseded by clm_1E22065402A1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 66,777,000,000 United States dollar
Abbott Laboratories total assets: 66,777,000,000 United States dollar, claim clm_A0B8EEF54F83 · ended · superseded by clm_36D0A18F3352 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 74,438,000,000 United States dollar
Abbott Laboratories total assets: 74,438,000,000 United States dollar, claim clm_A18A3F048BE2 · ended · superseded by clm_29B334F286FF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 995,000,000 United States dollar
Abbott Laboratories quarterly operating income: 995,000,000 United States dollar, claim clm_A2F6D8E3F671 · ended · superseded by clm_8F33F13465E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 72,467,000,000 United States dollar
Abbott Laboratories total assets: 72,467,000,000 United States dollar, claim clm_A3E39CBB1AE7 · ended · superseded by clm_73D720E01EFC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 70,908,000,000 United States dollar
Abbott Laboratories total assets: 70,908,000,000 United States dollar, claim clm_A40F2BAB5CB1 · ended · superseded by clm_4B97A512CC39 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,743,573,777 shares
Abbott Laboratories shares outstanding: 1,743,573,777 shares, claim clm_A47E0BC1EDCE · ended · superseded by clm_415D9C1703CA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 8,674,505,000 United States dollar
Abbott Laboratories quarterly revenue: 8,674,505,000 United States dollar, claim clm_A55F00358DA8 · ended · superseded by clm_E6DA945AC1D9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,580,667,737 shares
Abbott Laboratories shares outstanding: 1,580,667,737 shares, claim clm_A5733B5B97F8 · ended · superseded by clm_EC2D60D2CF76 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 627,476,000 United States dollar
Abbott Laboratories quarterly operating income: 627,476,000 United States dollar, claim clm_A62E02723D32 · ended · superseded by clm_102398756A32 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 39,637,000,000 United States dollar
Abbott Laboratories total assets: 39,637,000,000 United States dollar, claim clm_A72DE3456A35 · ended · superseded by clm_2A02207F2DFC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,470,483,000 United States dollar
Abbott Laboratories quarterly operating income: 1,470,483,000 United States dollar, claim clm_A7FED0A7C490 · ended · superseded by clm_0D38DCBAC1D9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,838,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,838,000,000 United States dollar, claim clm_A8B28B659942 · ended · superseded by clm_6CBAE76E6610 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,770,529,999 shares
Abbott Laboratories shares outstanding: 1,770,529,999 shares, claim clm_A9B16D8709AE · ended · superseded by clm_2A5B8E7E3E6F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,570,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,570,000,000 United States dollar, claim clm_AA75EDDF3D74 · ended · superseded by clm_D03CCE99B6F0 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · SIC industry · Pharmaceutical Preparations (2834)
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 41,950,000,000 United States dollar
Abbott Laboratories revenue: 41,950,000,000 United States dollar, claim clm_AC0EC8434FB1 · ended · superseded by clm_7C1D7352CFA6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,730,383,296 shares
Abbott Laboratories shares outstanding: 1,730,383,296 shares, claim clm_AC459049B414 · ended · superseded by clm_7B940234185D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 2,810,343,000 United States dollar
Abbott Laboratories cash and equivalents: 2,810,343,000 United States dollar, claim clm_AD5025D43C51 · ended · superseded by clm_DE2BC508C752 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · research and development · 2,844,000,000 United States dollar
Abbott Laboratories research and development: 2,844,000,000 United States dollar, claim clm_AD76C5C835C9 · ended · superseded by clm_0537D98543E9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 24,603,800,000 United States dollar
Abbott Laboratories total equity: 24,603,800,000 United States dollar, claim clm_B0304BE94341 · ended · superseded by clm_09169A44136C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,225,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,225,000,000 United States dollar, claim clm_B072725BD09E · ended · superseded by clm_B3E333AEC169 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 2,284,000,000 United States dollar
Abbott Laboratories net income: 2,284,000,000 United States dollar, claim clm_B11F523F3F14 · ended · superseded by clm_E00F0EE99100 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 2,740,156,000 United States dollar
Abbott Laboratories cash and equivalents: 2,740,156,000 United States dollar, claim clm_B1458938F400 · ended · superseded by clm_507982939D85 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 10,358,000,000 United States dollar
Abbott Laboratories quarterly revenue: 10,358,000,000 United States dollar, claim clm_B19E42064034 · ended · superseded by clm_E9EFA461ED0C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,244,000,000 United States dollar
Abbott Laboratories quarterly revenue: 5,244,000,000 United States dollar, claim clm_B233A6055639 · ended · superseded by clm_FD8317313DF1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 9,302,000,000 United States dollar
Abbott Laboratories cash and equivalents: 9,302,000,000 United States dollar, claim clm_B27DA681BF8C · ended · superseded by clm_26D15FF3B04A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 3,650,000,000 United States dollar
Abbott Laboratories operating income: 3,650,000,000 United States dollar, claim clm_B2ED5C0080DE · ended · superseded by clm_50D9545CB1D5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 72,548,000,000 United States dollar
Abbott Laboratories total assets: 72,548,000,000 United States dollar, claim clm_B337C7B6BC7D · ended · superseded by clm_3ACBA8D93D83 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,302,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,302,000,000 United States dollar, claim clm_B3E333AEC169 · ended · superseded by clm_489645837B5D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · research and development · 2,260,000,000 United States dollar
Abbott Laboratories research and development: 2,260,000,000 United States dollar, claim clm_B40728D6F627 · ended · superseded by clm_0556A1975396 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,647,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,647,000,000 United States dollar, claim clm_B41FB990A838 · ended · superseded by clm_FDE13F28F4C1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 36,686,000,000 United States dollar
Abbott Laboratories total equity: 36,686,000,000 United States dollar, claim clm_B43602CFF805 · ended · superseded by clm_BCA71643FBC3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 39,873,910,000 United States dollar
Abbott Laboratories revenue: 39,873,910,000 United States dollar, claim clm_B4C1932FF6FA · ended · superseded by clm_9516B11C6785 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 698,000,000 United States dollar
Abbott Laboratories quarterly research and development: 698,000,000 United States dollar, claim clm_B51405589AC1 · ended · superseded by clm_4031E5A84FE8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 466,000,000 United States dollar
Abbott Laboratories quarterly net income: 466,000,000 United States dollar, claim clm_B5440F9585CE · ended · superseded by clm_D2D95C54C305 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 68,427,000,000 United States dollar
Abbott Laboratories total assets: 68,427,000,000 United States dollar, claim clm_B5CB1DFE9334 · ended · superseded by clm_272419186E81 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 9,882,000,000 United States dollar
Abbott Laboratories cash and equivalents: 9,882,000,000 United States dollar, claim clm_B5EA4556B88D · ended · superseded by clm_14B748327E60 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 30,578,000,000 United States dollar
Abbott Laboratories revenue: 30,578,000,000 United States dollar, claim clm_B704D1D4A319 · ended · superseded by clm_1395DECF0604 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,488,757,318 shares
Abbott Laboratories shares outstanding: 1,488,757,318 shares, claim clm_B73D3A7A5FA7 · ended · superseded by clm_771836F657A2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 74,007,000,000 United States dollar
Abbott Laboratories total assets: 74,007,000,000 United States dollar, claim clm_B767032D0C72 · ended · superseded by clm_49EE0D525A68 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 21,874,000,000 United States dollar
Abbott Laboratories total equity: 21,874,000,000 United States dollar, claim clm_B7BFE3FD70B5 · ended · superseded by clm_D8D7C2D39205 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 31,362,000,000 United States dollar
Abbott Laboratories total equity: 31,362,000,000 United States dollar, claim clm_B7DCB616777F · ended · superseded by clm_E37A9F632E3D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,773,241,000 United States dollar
Abbott Laboratories quarterly revenue: 9,773,241,000 United States dollar, claim clm_B817BB7C1C39 · ended · superseded by clm_83226985F7C5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 2,018,000,000 United States dollar
Abbott Laboratories quarterly net income: 2,018,000,000 United States dollar, claim clm_B88C88ADFFAE · ended · superseded by clm_55CCFB617DE7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 67,234,944,000 United States dollar
Abbott Laboratories total assets: 67,234,944,000 United States dollar, claim clm_B8A0C7E5A98B · ended · superseded by clm_765D69CF45D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 22,855,627,000 United States dollar
Abbott Laboratories total equity: 22,855,627,000 United States dollar, claim clm_B8C5187C21F8 · ended · superseded by clm_85CABEE68CB1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 31,686,000,000 United States dollar
Abbott Laboratories total equity: 31,686,000,000 United States dollar, claim clm_B94747095EFB · ended · superseded by clm_6AC71DAEDCE7 · 1 source (1 primary) · conf 0.95

What the statuses mean